StockStory.org on MSN
Illumina (NASDAQ:ILMN) posts better-than-expected sales in Q1 CY2026
Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results , with sales up 4.8% year on year to $1.09 billion. The ...
From automation to lean process redesign, laboratories worldwide are transforming how they handle diagnostics to deliver faster, more accurate results. These changes address bottlenecks, reduce errors ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果